Business context and reporting period
Prestige Brands Holdings, Inc. (the filing issuer; the request metadata names Prestige Consumer Healthcare Inc.) markets and distributes OTC healthcare and household cleaning products. This Form 10-Q covers the fiscal second quarter and six months ended September 30, 2011; amounts below are in U.S. dollars unless noted.
Comparisons are affected by the Blacksmith acquisition, included from November 1, 2010, and the January 2011 Dramamine brand acquisition. The company reported OTC Healthcare and Household Cleaning as its two segments.
Financial performance and position
| Metric | Three months ended September 30, 2011 | Six months ended September 30, 2011 |
|---|---|---|
| Total revenue | $105.5 million, up 34.8% | $200.8 million, up 34.3% |
| Gross profit / margin | $53.9 million / 51.1%; prior-year margin 54.4% | $103.8 million / 51.7%; prior-year margin 53.9% |
| Operating income | $29.4 million, versus $23.8 million | $56.6 million, versus $44.5 million |
| Net income | $12.9 million, versus $11.0 million | $27.7 million, versus $20.6 million |
| Diluted EPS | $0.26, versus $0.22 | $0.55, versus $0.41 |
- Six-month operating cash flow was $33.5 million, down from $42.8 million. Investing activities provided $0.9 million; financing activities used $39.7 million, including $40.0 million of debt repayment.
- Cash was $8.0 million at September 30, 2011, down from $13.3 million at March 31, 2011. Current assets were $112.4 million and current liabilities $56.1 million.
- Debt principal was $452.0 million, down from $492.0 million; net carrying value was $447.4 million. The $202.0 million secured term loan carried a 4.75% average rate; $250.0 million of senior notes bear 8.25% interest. The company also reported $40.0 million of revolver availability and $75.0 million of incremental borrowing capacity.
- Blacksmith and Dramamine contributed $27.6 million of second-quarter revenue and $52.1 million for the six-month period. Acquired brands drove growth, while reported gross margins declined, primarily reflecting lower margins on acquired Blacksmith products and increased Household Cleaning promotions.
Changes, outlook, risks and unusual items
- OTC Healthcare revenue rose 55.7% in the quarter and 57.3% for six months, primarily from acquisitions. Household Cleaning revenue declined 3.9% and 6.5%, respectively; weaker Comet sales were a factor. Advertising and promotion expense increased substantially, including to support acquired and legacy OTC brands.
- Six-month interest expense increased to $16.9 million from $10.8 million, reflecting higher average debt related to acquisitions. Cash generation was lower year over year, which management attributed mainly to higher working capital needs, interest payments and incentive compensation.
- A June 2011 litigation resolution generated an $8.0 million payment; after $2.9 million of costs, the company recorded a $5.1 million pretax gain ($3.2 million after tax), classified outside ongoing operations. A $1.2 million Blacksmith escrow settlement reduced goodwill. The prior-year comparison included Cutex discontinued operations and a loss on sale.
- Management estimated a 38.7% effective tax rate for the remaining quarters of fiscal 2012, excluding discrete items, and expected covenant compliance in the ensuing year. No revenue or earnings guidance was provided. The company stated it was in compliance with debt covenants at September 30, 2011.
- Risks include customer concentration (one customer represented 18.2% of six-month gross revenue and 20.5% of receivables), dependence on third-party manufacturers and a single principal U.S. distribution center, pricing and input-cost pressures, acquisition integration, and substantial debt. A one-percentage-point increase in variable rates was estimated to reduce pretax earnings and cash flow by about $1.0 million for the remaining six months of fiscal 2012.
- The Trutek licensing dispute was in arbitration; closing arguments were scheduled for November 30, 2011, with a written decision to follow. The SFT litigation was settled and dismissed with prejudice without material impact. No goodwill or intangible impairment was recorded in the reported periods.
Important facts for investors to verify
- Confirm the issuer identity: this filing is for Prestige Brands Holdings, Inc., despite the request metadata naming Prestige Consumer Healthcare Inc.
- Assess how much reported growth and earnings reflect acquired brands, and whether acquired-brand margins and organic sales can improve.
- Review cash conversion and working-capital trends, given lower operating cash flow and increases in receivables and inventory.
- Check debt-repayment capacity, floating-rate exposure, covenant headroom and the restrictions on dividends and other corporate actions.
- Track the Trutek arbitration outcome, customer concentration, manufacturing and distribution continuity, and assumptions supporting goodwill and trademark valuations.